Ozempic (semaglutide) injection 1 mg

Ozempic (semaglutide) injection 1 mg is a weight-loss injection from Ozempic, listed for registered Australian clinics in our Weight loss range. Pack: 1 mg. Priced in AUD (A$54.00). Sydney dispatch, nationwide. Not a public treatment clinic.

About Ozempic (semaglutide) injection 1 mg

Ozempic (semaglutide) injection 1 mg

What is Ozempic

Ozempic is a prescription medication containing semaglutide, a GLP‑1 receptor agonist. It mimics the natural GLP‑1 hormone released after eating.

Key actions:

• stimulates insulin release when blood sugar is high
• reduces glucagon secretion, lowering glucose output from the liver
• slows gastric emptying, reducing appetite and increasing satiety
• improves blood glucose control
• supports weight reduction
• lowers the risk of cardiovascular events
• slows the progression of kidney disease in adults with type 2 diabetes

Uses

Ozempic is prescribed for adults to:

• improve blood sugar control in type 2 diabetes
• reduce the risk of heart attack, stroke, and cardiovascular death
• slow the progression of chronic kidney disease

Dosage and Administration

• administered once weekly, subcutaneously
• injection sites: abdomen, thigh, or upper arm (rotate sites weekly)
• use a new sterile needle for each injection
• hold the dose button for several seconds to ensure full delivery
• do not inject intravenously or intramuscularly

Missed Dose

• if less than 5 days have passed, the missed dose may be taken
• if more than 5 days have passed, skip the dose and resume the regular schedule

Storage

• before first use: refrigerate at 2–8°C
• after first use: may be stored at room temperature for up to 56 days
• do not freeze
• avoid direct sunlight and heat
• remove the needle after each injection

Common Side Effects

• nausea
• vomiting
• diarrhea
• abdominal pain
• constipation
• reduced appetite

Serious Risks

• thyroid C‑cell tumors (contraindicated in patients with MTC or MEN‑2)
• pancreatitis
• worsening diabetic retinopathy with rapid glucose improvement
• hypoglycemia when combined with insulin or sulfonylureas
• dehydration and kidney injury
• severe gastrointestinal reactions
• gallbladder disease
• allergic reactions

Additional Guidance

• carry the pen in hand luggage and avoid extreme temperatures
• dispose of used pens and needles in a sharps container
• follow dietary and physical activity recommendations
• consult a healthcare provider before pregnancy or breastfeeding

Summary

Ozempic is a once‑weekly injectable GLP‑1 receptor agonist for type 2 diabetes. It improves glucose control, reduces cardiovascular risks, and slows kidney disease progression. Proper administration, storage, and awareness of contraindications and side effects are essential for safe and effective use.

Minimum order – 5 pcs.

Ozempic (semaglutide) injection 1 mg — key details for ordering

• Product: Ozempic (semaglutide) injection 1 mg
• Brand: Ozempic
• Category: Weight loss > Ozempic
• Pack format: 1 mg
• Price: A$54.00 AUD, including GST where applicable
• Dispatch: Sydney, Australia-wide

Using Ozempic (semaglutide) injection 1 mg in clinic practice

Weight-loss injections differ by active ingredient, dose step and pen format. Check the strength and dose schedule on this page against the prescribing protocol you follow, store pens as the manufacturer directs, and confirm the quantity needed for a full treatment period before ordering.

Ordering Ozempic (semaglutide) injection 1 mg and related products

Compare Ozempic (semaglutide) injection 1 mg with Saxenda injector pen, Fitaro Semaglutide Injection physiological regulator of appetite and caloric intake, Tizaro Tirzepatide 2.5mg/5mg/7.5mg control high blood sugar, or browse the full Weight loss catalogue. Clinics ordering in volume can use our wholesale enquiry program (AUD $5,000 minimum). See also the clinic FAQ and delivery information. Active-ingredient background for Ozempic (semaglutide) injection 1 mg is covered in the reference article on Semaglutide, and Australian practitioners should confirm regulatory positionings with the TGA before use.